Henrik Horwitz

870 total citations
57 papers, 562 citations indexed

About

Henrik Horwitz is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pharmacology. According to data from OpenAlex, Henrik Horwitz has authored 57 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Henrik Horwitz's work include Hormonal and reproductive studies (14 papers), Sexual Differentiation and Disorders (10 papers) and Multiple Sclerosis Research Studies (8 papers). Henrik Horwitz is often cited by papers focused on Hormonal and reproductive studies (14 papers), Sexual Differentiation and Disorders (10 papers) and Multiple Sclerosis Research Studies (8 papers). Henrik Horwitz collaborates with scholars based in Denmark, United States and Austria. Henrik Horwitz's co-authors include Kim Dalhoff, Jón Trærup Andersen, Jette Lautrup Frederiksen, Signe Modvig, Espen Jimenez‐Solem, Matilda Degn, Henrik E. Poulsen, Finn Sellebjerg, Ida M. Heerfordt and Nis Andersen and has published in prestigious journals such as JAMA, Circulation and PLoS ONE.

In The Last Decade

Henrik Horwitz

45 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henrik Horwitz Denmark	13	208	127	83	73	67	57	562
Elpis Vlachopapadopoulou Greece	16	278 1.3×	172 1.4×	21 0.3×	181 2.5×	42 0.6×	63	762
Mike D. Smith United States	6	158 0.8×	86 0.7×	121 1.5×	39 0.5×	36 0.5×	12	1.0k
Debra Freedenberg United States	13	124 0.6×	355 2.8×	45 0.5×	36 0.5×	119 1.8×	20	1.1k
P. Almgren Sweden	16	263 1.3×	338 2.7×	25 0.3×	111 1.5×	38 0.6×	28	1.1k
Marguerite T. Littleton‐Kearney United States	17	356 1.7×	162 1.3×	54 0.7×	45 0.6×	109 1.6×	27	925
Patrick J. Mansky United States	15	30 0.1×	130 1.0×	51 0.6×	107 1.5×	30 0.4×	25	819
Markay Hopps United States	13	39 0.2×	236 1.9×	20 0.2×	36 0.5×	132 2.0×	22	753
Richard Spark United States	11	392 1.9×	138 1.1×	56 0.7×	57 0.8×	66 1.0×	15	659
Carla Maria Ramos Germano Brazil	13	93 0.4×	165 1.3×	14 0.2×	46 0.6×	26 0.4×	53	679
Hongjuan Fang China	13	135 0.6×	171 1.3×	19 0.2×	80 1.1×	36 0.5×	34	704

Countries citing papers authored by Henrik Horwitz

Since Specialization

Citations

This map shows the geographic impact of Henrik Horwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Horwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Horwitz more than expected).

Fields of papers citing papers by Henrik Horwitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Horwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Horwitz. The network helps show where Henrik Horwitz may publish in the future.

Co-authorship network of co-authors of Henrik Horwitz

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Horwitz. A scholar is included among the top collaborators of Henrik Horwitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Horwitz. Henrik Horwitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heerfordt, Ida M., et al.. (2025). Prescription drug use in breastfeeding mothers and infant exposure: A register‐based cohort study. British Journal of Clinical Pharmacology. 91(10). 2979–2987.

Heerfordt, Ida M., et al.. (2025). Allopurinol use and risk of multiple sclerosis. Multiple Sclerosis and Related Disorders. 94. 106299–106299. 2 indexed citations

Heerfordt, Ida M., Kim Dalhoff, Jón Trærup Andersen, et al.. (2025). Response by Windfeld-Mathiasen et al to Letter Regarding Article, “Cardiovascular Disease in Anabolic Androgenic Steroid Users”. Circulation. 152(16). e296–e297.

Heerfordt, Ida M., et al.. (2025). Toxic Epidermal Necrolysis and Mortality: A Danish Cohort Study With 30 Years of Follow‐Up. The Journal of Dermatology. 53(1). 35–40.

Heerfordt, Ida M., et al.. (2025). Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Associated With Mebendazole Use. Basic & Clinical Pharmacology & Toxicology. 137(2). e70086–e70086. 1 indexed citations

Heerfordt, Ida M., et al.. (2025). EudraVigilance insights: Suspected adverse drug reactions in infants through breastfeeding. British Journal of Clinical Pharmacology. 91(8). 2431–2436. 1 indexed citations

Horwitz, Henrik, et al.. (2025). Medication Use in Multiple Sclerosis: A Population‐Based Comparison With the General Danish Population. Annals of Clinical and Translational Neurology. 12(11). 2206–2213.

Heerfordt, Ida M., et al.. (2025). Disability pension among androgenic-anabolic steroid users. Scandinavian Journal of Public Health. 150359753–150359753.

Heerfordt, Ida M., Kim Dalhoff, Jón Trærup Andersen, et al.. (2025). Cardiovascular Disease in Anabolic Androgenic Steroid Users. Circulation. 151(12). 828–834. 13 indexed citations

10.

Dalhoff, Kim, et al.. (2024). Paliperidone poisoning and measurable plasma concentrations 2.5 years after last administered dose: A case report. British Journal of Clinical Pharmacology. 91(6). 1580–1585. 1 indexed citations

11.

Heerfordt, Ida M., et al.. (2024). Mortality Among Users of Anabolic Steroids. JAMA. 331(14). 1229–1229. 21 indexed citations

12.

Heerfordt, Ida M., et al.. (2024). Extensive androgen exposure and meningioma risk – A matched cohort study. Clinical Neurology and Neurosurgery. 239. 108217–108217. 5 indexed citations

13.

Heerfordt, Ida M., et al.. (2024). Excessive androgen exposure and risk of malignancies: A cohort study. Andrology. 13(2). 296–301. 3 indexed citations

14.

Heerfordt, Ida M., Elisabeth Framke, Mette Mogensen, et al.. (2024). Reevaluating the role of interferon‐beta in psoriasis pathogenesis: A registry‐based self‐controlled study. The Journal of Dermatology. 51(8). 1113–1116. 2 indexed citations

15.

Heerfordt, Ida M., et al.. (2024). Cutaneous manifestations of misuse of androgenic anabolic steroids: A retrospective cohort study. Journal of the American Academy of Dermatology. 90(5). 1047–1048. 7 indexed citations

16.

Horwitz, Henrik, et al.. (2023). Interferon-beta exposure in-utero and the risk of infections in early childhood. Multiple Sclerosis and Related Disorders. 77. 104867–104867.

17.

Subhi, Yousif, et al.. (2023). Risk of Central Serous Chorioretinopathy in Male Androgen Abusers. Ophthalmology and Therapy. 12(2). 1073–1080. 12 indexed citations

18.

Horwitz, Anna, et al.. (2023). Inferring glaucoma status from prescriptions, diagnoses, and operations data: A Danish nationwide study. PLoS ONE. 18(12). e0292439–e0292439. 1 indexed citations

19.

Schelde, Astrid Blicher, et al.. (2022). Intracranial Hemorrhage Following Anticoagulant Treatment in Denmark: Spontaneous Adverse Drug Reaction Reports Versus Real-World Data. Drug Safety. 45(4). 379–388. 3 indexed citations

20.

Horwitz, Henrik. (2014). The prognosis for patients suspected of optic neuritis.. PubMed. 44(3). 189–95. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact